Prothena (PRTA) Earnings Date & Reports

Prothena Corp PLC is a late-stage clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PRTA is expected to report earnings to fall 46.38% to 32 cents per share on August 10

Q2'26

Est.

$0.32

Q1'26

Beat

by $0.95

Q4'25

Beat

by $0.19

Q3'25

Beat

by $0.04

Q2'25

Missed

by $1.12

The last earnings report on May 07 showed earnings per share of 60 cents, beating the estimate of -34 cents. With 656.31K shares outstanding, the current market capitalization sits at 460.18M.

View a ticker or compare two or three

Compare

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

Annualized Return+19%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

PRTA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement